Zomepirac

zomepirac Struktur
33369-31-2
CAS-Nr.
33369-31-2
Bezeichnung:
Zomepirac
Englisch Name:
zomepirac
Synonyma:
zomepirac;ZXVNMYWKKDOREA-UHFFFAOYSA-N;5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid;1H-Pyrrole-2-acetic acid, 5-(4-chlorobenzoyl)-1,4-dimethyl-;2-(5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrol-2-yl)acetic acid
CBNumber:
CB6922366
Summenformel:
C15H14ClNO3
Molgewicht:
291.73
MOL-Datei:
33369-31-2.mol

Zomepirac Eigenschaften

Schmelzpunkt:
178-179°
Siedepunkt:
470.8±45.0 °C(Predicted)
Dichte
1.28±0.1 g/cm3(Predicted)
Löslichkeit
Methanol (Sparingly), Water (Slightly)
pka
pKa 4.57(H2O-EtOH (1:1 v/v)) (Uncertain)
Aggregatzustand
Solid
Farbe
Off-White to Yellow
Stabilität:
Hygroscopic

Sicherheit

Zomepirac Chemische Eigenschaften,Einsatz,Produktion Methoden

Weltgesundheitsorganisation (WHO)

Zomepirac, a nonsteroidal anti-inflammatory agent, was introduced in 1979 for the treatment of rheumatic disorders and the management of moderate to severe pain. By 1983 its use had been associated with serious allergic reactions, including five deaths from anaphylaxis. This led to voluntary withdrawal of the drug from markets worldwide by the major manufacturer.

Zomepirac Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Zomepirac Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alta Scientific Co., Ltd. 022-6537-8550 15522853686
sales@altasci.com.cn China 4515 55
Shaanxi Dideu Newmaterial Co., Ltd. 029-63373950 15353716720
1052@dideu.com China 10007 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9514 58

33369-31-2(Zomepirac)Verwandte Suche:


  • zomepirac
  • 5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid
  • 2-(5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrol-2-yl)acetic acid
  • ZXVNMYWKKDOREA-UHFFFAOYSA-N
  • 1H-Pyrrole-2-acetic acid, 5-(4-chlorobenzoyl)-1,4-dimethyl-
  • 33369-31-2
Copyright 2019 © ChemicalBook. All rights reserved